About Woodholme Gastroenterology Associates
Clinical Trials at Woodholme Gastroenterology Associates
During the past decade, Woodholme Gastroenterology Associates conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 7 clinical trials were completed, i.e. on
average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Woodholme Gastroenterology Associates" #1 sponsor was "Celgene" with 7 trials, followed by "Allergan" with 4 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Freenome Holdings Inc."
with 2 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Woodholme Gastroenterology Associates"
#1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Woodholme Gastroenterology Associates
According to Clinical.Site data, the most researched conditions in "Woodholme Gastroenterology Associates" are
"Crohn Disease" (4 trials), "Crohn's Disease" (4 trials), "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials) and "Eosinophilic Esophagitis" (2 trials). Many other conditions were trialed in "Woodholme Gastroenterology Associates" in a lesser frequency.
Clinical Trials Intervention Types at Woodholme Gastroenterology Associates
Most popular intervention types in "Woodholme Gastroenterology Associates" are "Drug" (20 trials), "Other" (5 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Ozanimod" (3 trials), "Relamorelin" (3 trials), "CC-93538" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Woodholme Gastroenterology Associates
The vast majority of trials in "Woodholme Gastroenterology Associates" are
22 trials for "All" genders.
Clinical Trials Status at Woodholme Gastroenterology Associates
Currently, there are NaN active trials in "Woodholme Gastroenterology Associates".
undefined are not yet recruiting,
8 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Woodholme Gastroenterology Associates,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Woodholme Gastroenterology Associates, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Woodholme Gastroenterology Associates
Woodholme Gastroenterology Associates has several departments that took part in Clinical trials: "Woodholme Gastroenterology Associates, PA" - 2 trials